United States · FDA National Drug Code directory
Loteprednol Etabonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72485-665_08a09440-b505-b2c9-e063-6394a90a0d76
- Product NDC
- 72485-665
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- Loteprednol Etabonate
- Labeler
- ARMAS PHARMACEUTICALS INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231026
- Source listing expiry
- 20261231
Source-listed ingredients
- LOTEPREDNOL ETABONATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (72485-665-05) / 5 mL in 1 BOTTLE, DROPPER · 72485-665-05
- 1 BOTTLE, DROPPER in 1 CARTON (72485-665-10) / 10 mL in 1 BOTTLE, DROPPER · 72485-665-10
- 1 BOTTLE, DROPPER in 1 CARTON (72485-665-15) / 15 mL in 1 BOTTLE, DROPPER · 72485-665-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →